SCHEMBL7254385

SCHEMBL7254385

COc1ccc2c(c1)[nH]c1cc(F)ccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
KDM4E B2RXH2 5/20 0.55
HSD17B10 Q99714 3/20 0.55
MAPT P10636 2/20 0.55
TSHR P16473 1/20 0.55
GFER P55789 1/20 0.55
ITK Q08881 1/20 0.55
MAPK13 O15264 2/20 0.52
MAPK12 P53778 2/20 0.52
MAPK11 Q15759 2/20 0.52
MAPK14 Q16539 2/20 0.52
HPGD P15428 2/20 0.51
RXFP1 Q9HBX9 1/20 0.51
DYRK1A Q13627 4/20 0.50
KIF11 P52732 1/20 0.50
DYRK3 O43781 1/20 0.50
CCNT1 O60563 1/20 0.50
CCNB2 O95067 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29533596 0.88 KDM4E (0.68) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL2330779 0.88 KDM4E (0.68) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL29507671 0.82 KIF11 (0.61) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL1517851 0.82 KIF11 (0.61) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL6009651 0.79 KDM4E (0.59) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL1181326 0.79 KDM4E (0.79) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL29670412 0.79 KDM4E (0.79) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL30115280 0.79 KDM4E (0.79) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL27218939 0.78 KDM4E (0.51) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL7250494 0.78 KDM4E (0.55) ALDH1A1MEN1KMT2AKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030040538-A1 Novel substituted tricyclic compounds ASAHI-KASEI KABUSHIKI KAISHA (JP) 2003-02-27 US disclosed
EP-1238973-A1 NOVEL SUBSTITUTED TRICYCLIC COMPOUNDS Asahi Kasei Kabushiki Kaisha (JP) 2002-09-11 EP disclosed
CN-1126473-A Carbazole derivatives with 17,20-lyase-inhibiting activity GLAXO GROUP LTD (GB) 1996-07-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030040538-A1 Novel substituted tricyclic compounds CPT1A, CBR1, NR1H3 ALDH1A1 1241/4885MEN1 4144/4885KMT2A 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.